House Appropriators Say FDA's Compounding Policies 'Overreach'

July 2, 2015 at 7:06 PM
House appropriators are demanding that FDA dramatically revise its compounding policies, suggesting in report language that the agency overreached its statutory authority by penning a memorandum of understanding that covers dispensing, and that the agency went against Congressional intent by prohibiting office-use compounding. The lawmakers ask FDA to revamp the MOU to remove dispensing and to scrap its ban on office-use compounding. The lawmakers tell FDA that office-use compounding, which FDA has deemed not permissible for traditional compounders, was intended...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.